We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information to support your recovery after COVID-19.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
From 13 May 2024 we are introducing a change to the procedure for new Marketing Authorisation (MA) applications, where a joint assessment of labels is requested.
Urgent public health message: UKHSA has been notified about an outbreak of food botulism in France involving a small number of British nationals.
Advice on names and presentation of nicotine-containing electronic cigarettes and refill containers on packaging.
Find out about the long-term effects some people can have after having COVID-19.
Check the tariff classification for flavour pods.
Check the tariff classification for a vlogging kit with ring light made of plastics.
Using an ecological momentary assessment to evaluate your digital health product.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Find out which types of food are zero-rated and which are standard-rated for VAT purposes.
Guidance for the veterinary pharmaceutical industry on applying for maximum residue limits (MRLs) in the UK.
Paper prepared by Kings College London (KCL) on the loss of smell and taste with COVID-19.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Check the tariff classification for dried peas processed as pea flour.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.